5.86
price down icon3.14%   -0.19
after-market After Hours: 5.80 -0.06 -1.02%
loading
Terns Pharmaceuticals Inc stock is traded at $5.86, with a volume of 4.02M. It is down -3.14% in the last 24 hours and up +4.64% over the past month. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
See More
Previous Close:
$6.05
Open:
$5.9
24h Volume:
4.02M
Relative Volume:
2.64
Market Cap:
$497.74M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-4.5426
EPS:
-1.29
Net Cash Flow:
$-79.09M
1W Performance:
-12.93%
1M Performance:
+4.64%
6M Performance:
-16.05%
1Y Performance:
-6.84%
1-Day Range:
Value
$5.785
$6.13
1-Week Range:
Value
$5.46
$7.14
52-Week Range:
Value
$4.32
$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name
Name
Terns Pharmaceuticals Inc
Name
Phone
650-525-5535 EXT.101
Name
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Name
Employee
66
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
TERN's Discussions on Twitter

Compare TERN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TERN
Terns Pharmaceuticals Inc
5.86 497.74M 0 -95.90M -79.09M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-31-24 Initiated Oppenheimer Outperform
Jun-22-23 Initiated Mizuho Buy
Jun-07-23 Initiated Jefferies Buy
May-31-23 Initiated ROTH MKM Buy
May-08-23 Initiated BMO Capital Markets Outperform
Feb-14-23 Initiated JMP Securities Mkt Outperform
Feb-07-23 Initiated UBS Buy
Sep-12-22 Initiated H.C. Wainwright Neutral
Sep-14-21 Resumed Goldman Buy
Mar-02-21 Initiated Cowen Outperform
Mar-02-21 Initiated Goldman Buy
Mar-02-21 Initiated JP Morgan Overweight
View All

Terns Pharmaceuticals Inc Stock (TERN) Latest News

pulisher
Dec 18, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 4.7%Should You Sell? - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Terns Pharmaceuticals' SWOT analysis: promising pipeline drives stock potential - Investing.com

Dec 17, 2024
pulisher
Dec 16, 2024

Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey

Dec 16, 2024
pulisher
Dec 12, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stake Reduced by Fmr LLC - MarketBeat

Dec 12, 2024
pulisher
Dec 11, 2024

Insider Spends US$110k Buying More Shares In Terns Pharmaceuticals - Simply Wall St

Dec 11, 2024
pulisher
Dec 11, 2024

Terns Pharmaceuticals CEO & Director Acquires 423% More Stock - Yahoo Finance

Dec 11, 2024
pulisher
Dec 11, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up Following Insider Buying Activity - Defense World

Dec 11, 2024
pulisher
Dec 10, 2024

Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock - Investing.com India

Dec 10, 2024
pulisher
Dec 09, 2024

Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock By Investing.com - Investing.com Canada

Dec 09, 2024
pulisher
Dec 08, 2024

17,369 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Bought by Intech Investment Management LLC - Defense World

Dec 08, 2024
pulisher
Dec 06, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa

Dec 06, 2024
pulisher
Dec 05, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones - Investing.com

Dec 05, 2024
pulisher
Dec 05, 2024

Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - MSN

Dec 05, 2024
pulisher
Dec 05, 2024

Walleye Capital LLC Takes $1.55 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Terns’s stock soars as analysts cheer leukemia data — and predict more gains - MSN

Dec 04, 2024
pulisher
Dec 04, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by Parkman Healthcare Partners LLC - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Cinctive Capital Management LP Buys Shares of 168,564 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Terns reports positive early results in CML drug trial By Investing.com - Investing.com Nigeria

Dec 04, 2024
pulisher
Dec 03, 2024

U.S. STOCKS BlackRock, Terns Pharma, PSQ Holdings - XM

Dec 03, 2024
pulisher
Dec 03, 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee under Nasdaq Listing Rule 5635(4) - Marketscreener.com

Dec 03, 2024
pulisher
Dec 03, 2024

Terns reports positive early results in CML drug trial - Investing.com

Dec 03, 2024
pulisher
Dec 03, 2024

Terns Pharmaceuticals Announces Positive Early Data from - GlobeNewswire

Dec 03, 2024
pulisher
Dec 03, 2024

Terns Pharma's CML Drug Shows 50% Response Rate in Phase 1 Trial, Strong Safety Profile - StockTitan

Dec 03, 2024
pulisher
Dec 03, 2024

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia - The Manila Times

Dec 03, 2024
pulisher
Dec 02, 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Dec 02, 2024
pulisher
Dec 02, 2024

Quantbot Technologies LP Has $1.01 Million Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Comparing Enliven Therapeutics (NASDAQ:ELVN) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World

Dec 02, 2024
pulisher
Dec 01, 2024

Bellevue Group AG Takes $8.69 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 01, 2024
pulisher
Nov 28, 2024

Acuta Capital Partners LLC Boosts Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Analysts Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $27.25 - Defense World

Nov 28, 2024
pulisher
Nov 27, 2024

Terns Pharmaceuticals (TERN) Stock Surges Over 5% Amid Biotech S - GuruFocus.com

Nov 27, 2024
pulisher
Nov 26, 2024

Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine

Nov 26, 2024
pulisher
Nov 25, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts By Investing.com - Investing.com Canada

Nov 25, 2024
pulisher
Nov 25, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 25, 2024
pulisher
Nov 22, 2024

Telemark Asset Management LLC Acquires Shares of 300,000 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication, EMA, PDMA, FDA Approvals, Epidemiology, Therapies, Companies by DelveInsight - The Globe and Mail

Nov 22, 2024
pulisher
Nov 21, 2024

104,535 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Purchased by Quest Partners LLC - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com

Nov 20, 2024
pulisher
Nov 19, 2024

Top 3 Health Care Stocks You'll Regret Missing In Q4Amarin Corp (NASDAQ:AMRN) - Benzinga

Nov 19, 2024
pulisher
Nov 18, 2024

Terns Pharmaceuticals appoints new board member - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewswire

Nov 18, 2024
pulisher
Nov 18, 2024

Terns Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com

Nov 18, 2024
pulisher
Nov 16, 2024

Terns Pharmaceuticals Inc (TERN) Stock Price & Chart | Trade Now - Capital.com

Nov 16, 2024
pulisher
Nov 16, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 8.7%Should You Sell? - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Steven Cohen's Strategic Acquisition in Terns Pharmaceuticals Inc - GuruFocus.com

Nov 16, 2024

Terns Pharmaceuticals Inc Stock (TERN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Cap:     |  Volume (24h):